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Abstract 
Background: Associations between kidney disease and periodontal disease are not well documented among 
Aboriginal people of Australia. The purpose of this investigation was to report and compare demographic, oral health, 
anthropometric and systemic health status of Aboriginal Australians with kidney disease and to compare against 
relevant Aboriginal Australians and Australian population estimates. This provides much needed evidence to inform 
dental health service provision policies for Aboriginal Australians with kidney disease.
Methods: Sample frequencies and means were assessed in adults represented in six datasets including: (1) 102 Abo‑
riginal Australians with kidney disease residing in Central Australia who participated in a detailed oral health assess‑
ment; (2) 312 Aboriginal participants of the Northern Territory’s PerioCardio study; (3) weighted estimates from 4775 
participants from Australia’s National Survey of Adult Oral Health (NSAOH); (4) Australian 2016 Census (all Australians); 
(5) National Health Survey 2017–2018 (all Australians) and; (6) Australian Health Survey: Biomedical Results for Chronic 
Diseases, 2011–2012 (all Australians). Oral health status was described by periodontal disease and experience of 
dental caries (tooth decay). Statistically significant differences were determined via non‑overlapping 95% confidence 
intervals.
Results: Aboriginal Australians with kidney disease were significantly older, less likely to have a tertiary qualification 
or be employed compared with both PerioCardio study counterparts and NSAOH participants. Severe periodontitis 
was found in 54.3% of Aboriginal Australians with kidney disease, almost 20 times the 2.8% reported in NSAOH. A 
higher proportion of Aboriginal Australians with kidney disease had teeth with untreated caries and fewer dental res‑
torations when compared to NSAOH participants. The extent of periodontal attachment loss and periodontal pocket‑
ing among Aboriginal Australians with kidney disease (51.0%, 21.4% respectively) was several magnitudes greater 
than PerioCardio study (22.0%, 12.3% respectively) and NSAOH (5.4%, 1.3% respectively) estimates.
Conclusions: Aboriginal Australians with kidney disease exhibited more indicators of poorer oral health than both 
the general Australian population and a general Aboriginal population from Australia’s Northern Territory. It is impera‑
tive that management of oral health among Aboriginal Australians with kidney disease be included as part of their 
ongoing medical care.
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Background
Oral health is an important indicator of overall health and 
wellbeing [1]. Poor oral health can co-exist with many 
chronic conditions, such as diabetes and chronic kidney 
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disease (CKD) [2–4]. Whilst the DMFT index provides 
an indicator of caries experience, its components can also 
be a useful proxy for access (or lack of access) to dental 
care and treatment received [5, 6].
Good oral health and provision of timely and appro-
priate dental services for Australians who have CKD 
and end-stage kidney disease (ESKD) is imperative, as 
pathology from the oral cavity contributes to overall 
inflammatory burden. Recent reports have shown the 
association of decline in kidney function and inflamma-
tion [7]. Furthermore, inflammation arising from peri-
odontitis impedes glycaemic management in people who 
have diabetes [2]. Finally, optimal oral health which is 
free of infection is necessary for suitability for waitlist-
ing for renal transplant [8]. Good oral health is especially 
essential for those undergoing renal transplantation, with 
transplantation inadvisable until all oral disease has been 
eradicated [9].
Both periodontal disease and untreated caries dispro-
portionately affect Aboriginal Australians and people of 
lower socio-economic status [10]. Many reasons explain 
this inequity and include differences in access to afford-
able and timely dental care [11]. The maldistribution of 
dental practitioners to capital cities and major centres has 
a major impact on dental service availability and acces-
sibility for those residing in regional or remote locations 
[12]. Nationally, 18% of Aboriginal Australians live in 
remote or very remote areas of Australia [13]. Although 
access to dental services in the Northern Territory is a 
priority for clients with dialysis-dependent ESKD across 
remote, regional and urban centres, this service need is 
often unmet.
The purpose of our study was to report demographic, 
oral health, anthropometric and systemic health status of 
Aboriginal Australians with kidney disease and to com-
pare against relevant Aboriginal Australians and Aus-
tralian population estimates. This new knowledge would 
inform current and future public health policy to miti-
gate oral health burden for Aboriginal Australians with 
kidney disease.
Methods
Data describing oral health among Aboriginal people 
with and without kidney disease (102 and 312 respec-
tively) and the general population were derived from 
detailed research studies in the Northern Territory, and 
from four nationally representative health datasets. The 
study involving Aboriginal adults with kidney disease 
was based in two Central Australian locations in partner-
ship with both government and private dialysis units, and 
government dental clinics. Study participants comprised 
patients aged over 18  years who had a history of CKD, 
including ESKD requiring dialysis. The study aims were 
to describe the extent and severity of periodontal dis-
ease among a group of Aboriginal adults with CKD and 
to examine the effects of a comprehensive periodontal 
intervention among an Aboriginal population with CKD 
[14]. Thirty-two Aboriginal Australians with kidney dis-
ease did not undergo an oral assessment due to coagu-
lation risk or feeling unwell during the data collection 
phase. This meant that sociodemographic data was avail-
able for 102 Aboriginal adults with CKD, while clinical 
dental data was available for 70. The first comparison 
was against 312 Aboriginal Australians without kidney 
disease who took part in the screening process for the 
PerioCardio study (based in Darwin, Katherine and Alice 
Springs). To be eligible for the PerioCardio study, partici-
pants needed to be aged 18+ years and to have periodon-
tal disease (ascertained from the screening). The aims of 
the PerioCardio study were to describe the extent and 
severity of measures of vascular health and inflammation 
in Aboriginal Australians with moderate or severe perio-
dontal disease, to determine if there was a dose–response 
relationship between extent and severity of periodontal 
disease and measures of vascular health and inflamma-
tion, and to determine whether periodontal treatment 
influences vascular health and inflammation among Abo-
riginal Australians with moderate to severe periodontal 
disease [15]. Sociodemographic data was available for 
312 PerioCardio study participants, while clinical den-
tal data was available for 273. Other population-level 
comparisons included: (1) weighted estimates from 
4,775 National Survey of Adult Oral Health 2004–2006 
(NSAOH) participants [16]; (2) 2016 Australian Census 
data [17]; (3) National Health Survey (NHS) 2017–2018 
[18] and; (4) Australian Health Survey (AHS): Biomedical 
Results for Chronic Diseases, 2011–2012 [19]. Across all 
six datasets we examined demographic, oral health and 
biomedical estimates.
Oral assessment
Oral assessments replicated the methods used in 
NSAOH [20]. Collected data included tooth presence, 
caries experience, periodontal destruction, gingival 
bleeding, dental plaque and calculus scores. A single car-
ies experience score was recorded for each tooth using 
the following hierarchy: sound, filled due to caries, filled 
unsatisfactorily (defective restorations without decay), 
recurrent caries (new decay around existing filling) and 
decayed. Dental plaque and calculus were recorded for 
six teeth, which were the most anterior molar in each 
quadrant, in addition to the maxillary right central and 
mandibular left central incisors (if present) [21]. Peri-
odontal probing depth (PPD) and gingival recession to 
calculate clinical attachment level (CAL) was measured 
at four sites of every tooth excluding third molars, which 
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included the mesio-buccal, mid-buccal, disto-buccal and 
disto-palatal/lingual. ‘Moderate’ or ‘severe’ periodon-
tal disease was determined by combining PPD and CAL 
based on the Centres for Disease Control and Prevention 
and the American Academy of Periodontology 2012 case 
definition [21]. Gingival bleeding on probing (BOP) was 
based on the established Gingival Index criteria [22].
Other clinical measurements
Height was measured to the nearest 0.1  cm using a 
portable stadiometer (Seca 213, Hamburg, Germany). 
Weight was measured to the nearest 0.1 kg using a port-
able weight scale (Tanita HD-351, Arlington Heights, 
USA) with participants lightly clothed. Body mass index 
(BMI) was calculated as weight (kg) divided by the 
square of height (m). Systolic and diastolic blood pres-
sure was measured using the SphygmoCor XCEL device 
that automates measurement using a brachial cuff via 
three one-minute cuff inflation cycles, and central blood 
pressure estimated by use of a proprietary general trans-
fer function (AtCor Medical, Sydney). Bilateral carotid 
intima-media thickness was asssessed by high-resolu-
tion ultrasound from a single angle of convenience from 
both left and right carotid arteries in the PerioCardio 
study [15], and from up to 3 angles per carotid artery in 
the study involving Aboriginal Australians with kidney 
disease.
Statistical analysis
All data were restricted to study participants aged 
between 18 and 80 years to reflect the age distribution in 
the sample of Aboriginal Australians with renal disease. 
Sample frequencies and means along with their respec-
tive 95% confidence intervals were generated to enable 
comparisons across datasets. Statistically significant dif-
ferences were denoted by non-overlapping 95% confi-
dence intervals (CIs). Whenever there is a lack of overlap 
between 95% CIs for two groups, it is a mathematical cer-
tainty that a hypothesis test of the difference between the 
same two groups would yield a P-value of less than 0.05. 
In order to calculate the standard deviation of mean val-
ues reported in both the NHS and AHS from the stand-
ard error, the following formula was used: SD = SE
√
N  . 
To account for differences in the number of teeth 
between study samples, extent scores using the methods 
described by Carlos and colleagues [21] were generated 
to permit comparisons of CAL, PPD and BOP. All analy-
ses were performed using SAS 9.4 (Cary, NC, USA).
Results
Data were available for 102 Aboriginal Australians with 
renal disease; 85 with ESKD (83%) and 17 non-ESKD 
(17%). The average age was 48.1  years and the majority 
had achieved only up to a school education level (74.7%) 
(Table  1). When comparing against other population 
estimates, the average age of Aboriginal Australians 
with kidney disease was significantly higher than par-
ticipants enrolled in the PerioCardio study (41.0  years) 
and NSAOH (40.0 years) (Table 1). A higher proportion 
of Aboriginal Australians with kidney disease had com-
pleted school-only education and were unemployed or 
not seeking work when compared to PerioCardio study 
estimates (total proportion 46.3%), NSAOH participants 
(total proportion 37.0%) or the Australian population 
(total proportion 35.7%). Most Aboriginal Australian 
participants with renal disease were unemployed (52.7%) 
or not seeking work (33.3%). The proportion of Aborigi-
nal Australians with kidney disease who were current 
smokers was 38 percent. The proportion of Aboriginal 
Australians with kidney disease who were current smok-
ers was half that of PerioCardio study participants. How-
ever, Aboriginal Australians with kidney disease were 
twice as likely to be current and half as likely to be former 
smokers compared to the Australian population and the 
NSAOH sample (Table 1).
Of the 70 Aboriginal Australians with kidney disease 
who provided clinical oral health data, almost all (92.9%) 
had ‘moderate’ or ‘severe’ periodontitis. The estimate for 
‘moderate’ or ‘severe’ periodontitis for Aboriginal Aus-
tralians with kidney disease was significantly greater 
than the 25.9% in NSAOH. The prevalence of ‘severe’ 
periodontitis was two times higher among Aboriginal 
Australians with kidney disease (54.3%) compared with 
the PerioCardio study participants (26.8%) and almost 
20 times higher than general Australian population esti-
mates (2.8%).
The mean number of teeth with untreated caries among 
Aboriginal Australians with kidney disease was 3.2 which 
was five times higher than that reported for NSAOH 
participants (0.6), but not significantly different to esti-
mates from the PerioCardio study (3.0) (Table  2). Just 
over half had periodontal clinical attachment loss (CAL) 
of 4  mm or more. The extent of sites with periodontal 
pocket depth (PPD) of 4 mm or more was 21.4%, while 
31.9% experienced moderate or heavy bleeding on prob-
ing. Examining historical evidence of periodontal disease, 
Aboriginal Australians with kidney disease exhibited 
more than twice the number of sites with CAL ≥ 4  mm 
compared with PerioCardio participants (22.0%); this 
was tenfold higher than that of national survey estimates 
of the Australian population (5.4%). In reference to the 
presence of current disease, a two-fold difference in the 
extent of sites with PPD ≥ 4  mm and ‘moderate’/’heavy’ 
bleeding on probing was seen between Aboriginal Aus-
tralians with kidney disease and PerioCardio study par-
ticipants (12.3% and 16.0% respectively).
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Table 1 Socio-demographic characteristics of Aboriginal Australians with kidney disease in Central Australia compared 
with PerioCardio participants and other population estimates
1 2016 Australian Census (limited to 18–80 years of age)
2 National Health Survey First Results 2017–2018 (18 + years of age)
* Mean (95% CI) reported
**  Community Development Employment Project, a government-initiated employment scheme
# CDC-AAP 2007 case definition
a Proportion around 95% CI from PerioCardio study combines unemployed, not seeking work, retired, disability
Aboriginal Australians with kidney disease 
in Central Australia % (95% CI) (N = 102)
PerioCardio study % 
(95% CI) (N = 312)
NSAOH 2004–2006% 




Mean (SD) age* 48.11 (45.57, 50.65)† 40.01 (38.87, 41.15)† 44.84 (44.09, 45.59) –
Sex1
Female 60.8 (51.1, 70.4)† 44.2 (38.7, 49.8)† 50.3 (48.4, 52.1) 50.8
Male 39.2 (29.6, 48.9)† 55.8 (50.2, 61.3)† 49.7 (47.9, 51.6) 49.2
Highest school level completed1
Nil/primary 30.3 (20.6, 40.1)† 13.1 (9.2, 17.1)† 2.3 (1.8, 2.8)† 0.9
Years 8/9 32.6 (22.7, 42.5) 20.8 (16.1, 25.5) 6.9 (6.0, 7.8)† 9.0
Years 10/11 22.5 (13.6, 31.3)† 42.6 (36.8, 48.3)† 30.8 (29.0, 32.7) 29.6
Year 12 14.6 (7.1, 22.1)† 23.5 (18.6, 28.4) 60.0 (57.9, 62.1)† 60.5
Post-school qualification1
Nil/school only 74.7 (65.6, 83.8)† 50.3 (44.6, 56.1)† 36.8 (34.8, 38.8)† 42.2
Trade/apprenticeship 3.3 (0.0, 7.0)† 5.5 (2.9, 8.2) 14.1 (12.7, 15.4)† 30.4b
Certificate/diploma 18.7 (10.5, 26.8)† 33.4 (28.0, 38.9)† 12.4 (11.1,13.7)
University degree 3.3 (0.0, 7.0)† 10.7 (7.1, 14.3)† 36.8 (34.6, 38.9)† 27.4
Employment status1
CDEP** 3.2 (0.0, 6.9) 5.4 (2.7, 8.0) – –
Full‑time 4.3 (0.1, 8.5)† 42.3 (36.5, 48.1)† 28.0 (11.4, 44.5)† 42.4
Part‑time 6.5 (1.4, 11.5) 6.1 (3.3, 8.9) 35.0 (18.2, 51.8) 21.9
Unemployed 52.7 (42.4, 63.0)† 6.5 (3.6, 9.4)† 37.0 (19.9, 54.2)a 4.5
Not seeking work/retired/
disability
33.3 (23.6, 43.1) 39.8 (34.0, 45.6) 31.2
Main source of income
Government benefits 87.2 (80.4, 94.1)† 21.2 (16.4, 26.1)† 29.7 (27.8, 31.5) –
Wages/salary 6.4 (1.3, 11.4)† 46.0 (40.1, 51.9)† 68.3 (66.5, 70.1) –
Student ‑ 1.1 (0.0, 2.3) 2.0 (1.3, 2.7) –
Other 6.4 (1.3, 11.4)† 31.7 (26.2, 37.2)† – –
Smoking status2
Current 38.4 (27.9, 48.9)† 66.1 (60.2, 72.1)† 17.0 (15.5, 18.6)† 15.1 (14.6, 15.7)†
Former 12.8 (5.6, 20.0)† 10.6 (6.7, 14.5) 29.2 (27.6, 30.7)† 29.2 (28.5, 29.8)†
Never 48.8 (38.1, 59.6)† 23.3 (17.9, 28.6)† 53.8 (51.9, 55.7) 55.7 (55.0, 56.4)
Chew tobacco
Yes 21.7 (13.2, 30.3)† 5.3 (2.7, 7.9)† – –
No 78.3 (69.7, 86.8)† 94.7 (92.1, 97.3)† – –
Standard alcohol drinks/week2
None 56.6 (45.2, 68.0)† 36.4 (30.6, 42.2)† ‑ 43.9 (43.2, 44.7)†
1–7 drinks 27.6 (17.3, 37.9) 33.1 (27.5, 38.7) – 38.9 (38.2, 39.6)
8–19 drinks 6.6 (0.9, 12.3) 11.0 (7.3, 14.8) – 6.3 (6.0, 6.7)
20 or more 9.2 (2.6, 15.9) 19.5 (14.7, 24.2) – 9.8 (9.4, 10.2)
Periodontal case status#
Non‑case or mild 7.1 (1.0, 13.3)† 12.6 (8.9, 16.3) 74.1 (72.3, 75.9)† –
Moderate 38.6 (26.9, 50.3)† 60.6 (55.2, 66.1)† 23.1 (21.5, 24.7)† –
Severe 54.3 (42.3, 66.2)† 26.8 (21.8, 31.7)† 2.8 (2.2, 3.4)† –
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The mean systolic blood pressure of Aboriginal Aus-
tralians with renal disease was 143 mmHg, significantly 
higher than estimates from both the general Austral-
ian population (123 mmHg) and from the PerioCardio 
study (125 mmHg) (Table 3). Mean HbA1c was higher 
among Aboriginal Australians with kidney disease 
(54.4  mmol/mol) compared with national estimates 
(36.2  mmol/mol; data on HbA1c in national samples 
stratified by diabetes not available), and estimates from 
the PerioCardio study (45.0  mmol/mol) although the 
95% confidence intervals overlapped. The mean total 
cholesterol of Aboriginal Australians with renal disease 
was 4.05  mmol/L, while the mean total cholesterol to 
high-density lipoprotein ratio was 5.5. Whilst the total 
cholesterol of Aboriginal Australians with kidney dis-
ease was significantly lower than both PerioCardio 
participants (5.0  mmol/L) and Australian estimates 
(5.1 mmol/L), the total cholesterol to high-density lipo-
protein ratio was significantly higher among Aborigi-
nal Australians with kidney disease when compared to 
Australian estimates (3.7).
Discussion
This investigation highlights stark differences in the oral 
health of Aboriginal Australians with kidney disease 
in terms of periodontal disease and dental caries when 
compared with estimates from both the general Aus-
tralian population and against another sample of Abo-
riginal Australian adults from the Northern Territory. 
Of Aboriginal Australians with kidney disease who were 
screened, only 7.5% did not have moderate or severe per-
iodontal disease, and the prevalence of those with severe 
periodontal disease was 20 times that reported for the 
general Australian population. While we expected peri-
odontal disease to be more prevalent and more severe 
among people with kidney disease [23], the magnitude of 
poorer oral health among adults with CKD was striking.
Others have cited high prevalence of periodontal dis-
ease among CKD and ESKD patients. In Romania, Ves-
sia and colleagues reported that among 101 hemodialysis 
patients with ESKD (mean age 53  years), estimates of 
periodontal disease, calculus index and bleeding on prob-
ing were on par with those reported in our study [24]. In 
b Proportion from 2016 Australian Census combines Trades, apprenticeship, certificate and vocational diploma
† denotes non-overlapping 95% confidence intervals
Table 1 (continued)
Table 2 Oral health parameters of  Aboriginal Australians with  kidney disease in  Central Australia compared 
with PerioCardio participants and Australian population estimates
* six index sites examined
DMFT: mean number of decayed, missing and filled teeth
AL: attachment loss
PPD: periodontal pocket length
BOP: bleeding on probing
† denotes non-overlapping 95% confidence intervals
Aboriginal Australians with kidney 
disease in Central Australia
mean (95% CI) (N = 70)
PerioCardio study mean (95% 
CI) (N = 273)
NSAOH 2004–2006 
mean (95% CI) 
(N = 4,775)
Number of teeth 24.34 (22.89, 25.79)† 26.50 (25.86, 27.14)† 25.59 (25.38, 25.79)
Number of decayed teeth 3.17 (2.47, 3.87)† 3.02 (2.64, 3.40) 0.59 (0.53, 0.66)†
Number of missing teeth 6.40 (4.92, 7.88)† 3.83 (3.22, 4.44)† 4.92 (4.68, 5.17)
Number of filled teeth 1.29 (0.81, 1.76)† 2.87 (2.46, 3.28)† 8.49 (8.21, 8.78)†
DMFT 10.86 (9.20, 12.51)† 9.72 (8.88, 10.56) 14.01 (13.60, 14.42)†
Mean pocket depth 2.82 (2.63, 3.01)† 2.32 (2.25, 2.38)† –
Extent AL ≥ 4 mm (%) 51.03 (42.87, 59.19)† 21.96 (19.42, 24.50)† 5.37 (4.93, 5.82)†
Extent PPD ≥ 4 mm (%) 21.38 (16.14, 26.62)† 12.26 (10.74, 13.79)† 1.31 (1.03, 1.59)†
Extent PPD ≥ 6 mm (%) 3.48 (0.82, 6.14) 1.15 (0.82, 1.48) –
Extent AL ≥ 3 mm & PPD ≥ 4 mm (%) 20.49 (15.41, 25.56)† 12.10 (10.59, 13.61)† 1.20 (1.02, 1.38)†
Extent index sites with calculus (%)* 88.61 (82.98, 94.24) – –
Extent index sites with ‘moderate’/ ‘heavy’ 
plaque (%)*
79.39 (70.65, 88.14) – –
Extent ‘moderate’/ ‘heavy’ BOP (%) 31.93 (21.45, 42.40)† 16.01 (13.94, 18.09)† –
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a review of periodontal disease among patients receiving 
dialysis, Miyata and colleagues reported that periodontal 
diseases affected inflammation, the immune response, 
and nutritional status of patients on dialysis, with the 
severity of periodontal disease being significantly asso-
ciated with CRP, albumin, IL-6 and TNF-α [25]. The 
authors demonstrated how dialysis exacerbates oral con-
ditions via disruption of salivary characteristics (mainly 
pH and flow rate) which, in turn, contributes to severity 
of periodontal disease. They concluded that treatment 
and maintenance of oral health are important for quality 
of life, prevention of pathological conditions and prolon-
gation of survival among dialysis patients.
It is important to discuss inequity in relation to 
access to preventive health care (including dental 
health care) in the context of our findings. Aboriginal 
Australians with kidney disease were older, resided in 
a remote location, had attained a lower level of formal 
education, were less likely to be employed, and more 
likely to be receiving government benefits as their main 
source of income when compared with other popula-
tions included in this study. Indeed, our group has pre-
viously reported the association between indicators 
of CKD and disadvantage [26], and there is a regional 
variation in CKD among the wider Australian popula-
tion [27]. People with end-stage kidney disease require 
either haemodialysis, peritoneal dialysis or a kidney 
transplant to survive [28]. The majority of Aboriginal 
Australians with kidney disease in our sample undergo 
haemodialysis in thrice-weekly sessions lasting up to 
five hours. Under these circumstances, engaging in 
regular employment can be challenging due to co-exist-
ing health conditions, and thus financial support with 
government benefits was not unexpected. In a study 
involving 2,914 adults with moderate-to-severe CKD 
across 14 countries, Morton and colleagues showed 
how 32% were living in relative poverty, defined as 
having a household income < 50% of country median 
income, at study commencement. Amongst those not 
living in relative poverty at study commencement, 22% 
were living in poverty by study end 5  years later [29]. 
The authors concluded that progression of CKD  is 
associated with increased odds of falling into poverty, 
with kidney transplantation being a potential mitigat-
ing factor against this. In relation to our findings, pov-
erty among Aboriginal Australians with kidney disease 
likely contributes to the many challenges they may face 
in seeking and receiving timely dental care.
Table 3 Anthropometric and biomedical characteristics of Aboriginal Australians with kidney disease in Central Australia 
compared to PerioCardio participants and Australian population estimates
1 National Health Survey First Results 2017–2018, 4364.0.55.001 (participants 18 + years of age)
2 Australian Health Survey: Biomedical Results for Chronic Diseases, 2011–12, 4364.0.55.005 (participants 18 + years of age)
Australian Health Survey 2017–2018: https ://www.abs.gov.au/AUSST ATS/abs@.nsf/Detai lsPag e/4364.0.55.00120 17-18?OpenD ocume nt
95% CI calculator for mean: https ://www.socsc istat istic s.com/confi dence inter val/defau lt2.aspx SE converter for SD: https ://handb ook-5-1.cochr ane.org/chapt 
er_7/7_7_3_2_obtai ning_stand ard_devia tions _from_stand ard_error s_and.htm
† Denotes non-overlapping 95% confidence intervals
Central Australian Aboriginal Australians 
with kidney disease mean (95% CI) (N = 102)
PerioCardio study mean 




Weight (kg) 81.41 (75.49, 87.32) 84.17 (81.62, 86.71) 79.40 (78.81, 79.99)
Body mass  index1 29.20 (26.91, 31.48) 29.16 (28.29, 30.02) 28.10 (27.46, 28.75)
Waist to hip ratio 0.97 (0.94, 1.00) 0.94 (0.93, 0.95) –
Sitting systolic BP (mmHg)1 143 (136, 151)† 125 (123, 127) 123 (122, 123)
Sitting diastolic BP (mmHg)1 85 (80, 89)† 80 (79, 81) 77 (77, 77)
Max. carotid intima‑media thickness 0.80 (0.70, 0.90) 0.86 (0.82, 0.89) –
HbA1c (mmol/mol)2 54.42 (46.04, 62.81)† 44.97 (42.95, 46.99) 36.20 (35.81, 36.59)
eGFR (mL/min/1.73m2)2 32.62 (17.79, 47.45)† – 85.50 (85.30, 85.70)
Urine albumin 1,364.31 (24.91, 2,703.71) 41.92 (18.71, 65.13) ‑
Urine creatinine 10.05 (5.95, 14.14) 7.92 (7.15, 8.69) –
Urine albumin‑creatinine ratio (mg/g)2 250.19 (19.86, 480.52)† 7.26 (3.74, 10.78) 2.2 (− 16.03, 20.43)
Total cholesterol (mmol/L)2 4.05 (3.66, 4.44)† 4.98 (4.85, 5.12) 5.1 (4.51, 5.69)
Triglycerides (mmol/L)2 2.43 (1.90, 2.96) 2.53 (2.30, 2.76) 1.3 (− 0.66, 3.26)
HDL cholesterol (mmol/L)2 0.82 (0.70, 0.94)† 1.04 (1.00, 1.08) 1.3 (0.52, 2.08)
LDL cholesterol (mmol/L)2 2.16 (1.86, 2.45)† 2.91 (2.78, 3.04) 3.1 (2.32, 3.88)
Total/HDL cholesterol  ratio2 5.48 (4.69, 6.27) 5.22 (4.98, 5.45) 3.73 (2.95, 4.51)
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We also report differences in tooth loss among Aborig-
inal people of the Northern Territory with and without 
kidney disease. Tooth loss is the end-point of periodon-
tal disease, equivalent to amputation in medicine. Con-
sequently, loss of teeth eliminates the previous history 
of periodontal disease (and caries), but also serves to 
underestimate oral disease experience [30]. The extent of 
PPD, CAL and BOP findings presented in Table 2, which 
account for tooth loss, indicates that the number of areas 
throughout the mouths of Aboriginal Australians with 
kidney disease affected by periodontal disease is double 
that of the PerioCardio study participants. The NSAOH 
estimated in 2007 that approximately 30% of Aboriginal 
adults had periodontal disease [16]. Several observational 
studies involving Aboriginal people in urban and remote 
locations all posit that periodontal disease is much more 
common than in the non-Aboriginal Australian popula-
tion [31, 32].
Cigarette smoking was attributed to 38.5 million cases 
of periodontal disease globally in 2015 [33]. Australian 
estimates from NSAOH reported that smoking contrib-
uted to 700,000 cases of ‘moderate’ or ‘severe’ periodon-
tal disease [34]. The key mechanism by which cigarette 
smoking or tobacco chewing causes periodontal disease 
is by interfering with vascular and immunologic reac-
tions, as well as by undermining the supportive functions 
and wound healing capabilities of the periodontal tissues 
[35]. The prevalence of cigarette smoking has steadily 
decreased in Australia in response to strict tobacco legis-
lation and a raft of measures including marked increases 
in taxation and plain packaging laws [36]. This key pub-
lic health policy has contributed to an 8.6% reduction in 
smoking rates among Aboriginal Australian adults from 
50% in 2004 to 41.4% in 2015 [37]. In this light, the fre-
quency of current smokers among Aboriginal Austral-
ians with kidney disease at 32.5% is lower than the latest 
Aboriginal Australian population estimate; however, 
exposure to tobacco in our sample was offset with almost 
1-in-5 reporting they regularly chewed tobacco. This is 
consistent with previous Central Australian data and 
reflects differences between the Central Australia regions 
and Top End (hence between the Aboriginal Australians 
with kidney disease and PerioCardio study estimates) 
[38]. Whilst tobacco use is a major cardiovascular disease 
(CVD) risk factor, and CVD a major co-morbid condition 
of adults with CKD, we are unaware of reports describing 
successful smoking cessation among Aboriginal adults 
with CVD and/or CKD.
Untreated caries is a major contributor to dental pain 
affecting mastication (chewing), which directly affects 
dietary choices, malnutrition risk and quality of life 
[39]. Periodontal disease is not usually painful unless 
abscesses develop. However, periodontal disease does 
impact on quality of life through loss of function 
and aesthetics [40]. In this study, there was a higher 
amount of untreated caries, and lower number of filled 
teeth among Aboriginal Australians with kidney dis-
ease compared with both PerioCardio and NSAOH 
participants. Both indicators (caries and filled teeth) 
may reflect individual-level dental seeking behaviours 
or oral health services accessibility. Combined with the 
higher mean number of missing teeth, we speculate 
that among this sample of Aboriginal Australians with 
kidney disease there was a high level of oral health 
seeking behaviour for management (tooth extraction), 
which is consistent with other studies involving Abo-
riginal Australians [41–43]. It is worth noting that 
inadequate access to health services for Aboriginal 
Australians with kidney disease is not limited to den-
tal services. Morton and colleagues demonstrated in 
a systematic review among adults with moderate-to-
severe CKD, that socially disadvantaged pre-dialysis 
and dialysis patients experience poorer access to spe-
cialist cardiovascular health services, higher rates of 
cardiovascular events and mortality than their more 
advantaged counterparts [44].
The most significant relevant bias relates to the dif-
ferent designs of the included studies: the study involv-
ing Aboriginal Australians with kidney disease and the 
PerioCardio study were both convenience studies, while 
the four other datasets were representative, population-
level surveys (with weighted estimates) or the Cen-
sus. Potential participants for both the study involving 
Aboriginal Australians with kidney disease and the 
PerioCardio study were invited to be involved in a peri-
odontal health project, which clearly caused selection 
bias with the samples thus not being representative. In 
both studies, there was no dental pre-screening done by 
those who referred potential participants to the study 
team. There have not been any truly population-repre-
sentative studies reporting oral health and prevalence 
of periodontal disease among the Aboriginal Australian 
population, especially the population with kidney dis-
ease. We recommend additional research to report this.
In this observational study, we report poorer oral 
health status of Aboriginal Australians with kidney dis-
ease than the general Australian population, but also 
compared with other Aboriginal Australian adults liv-
ing in the Northern Territory. Because of the profound 
health impacts and reduced quality of life associated 
with untreated periodontal disease and dental caries, 
the findings reinforce the importance of making and 
keeping oral health a priority action area for all people 
with kidney disease.
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Conclusions
Aboriginal Australians with kidney disease exhibited 
more indicators of poorer oral health than both the 
general Australian population and a general Aborigi-
nal population from Australia’s Northern Territory. It is 
imperative that management of oral health among Abo-
riginal Australians with kidney disease be included as 
part of their ongoing medical care.
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